摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-氯-4-(2-丙炔-1-基氧基)苯 | 19130-39-3

中文名称
1-氯-4-(2-丙炔-1-基氧基)苯
中文别名
——
英文名称
1-chloro-4-(prop-2-yn-1-yloxy)benzene
英文别名
1-chloro-4-(prop-2-ynyloxy)benzene;1-chloro-4-prop-2-ynoxybenzene
1-氯-4-(2-丙炔-1-基氧基)苯化学式
CAS
19130-39-3
化学式
C9H7ClO
mdl
MFCD09836692
分子量
166.607
InChiKey
USRMDNZIKVMDKH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    83-84 °C(Press: 3 Torr)
  • 密度:
    1.171±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2909309090
  • 储存条件:
    2-8°C

SDS

SDS:f8d7f056ba227975677062ca09a26518
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    1-氯-4-(2-丙炔-1-基氧基)苯copper(l) iodide 、 trans-bis(triphenylphosphine)palladium dichloride 、 palladium 10% on activated carbon 、 氢气三乙胺 作用下, 以 四氢呋喃甲醇乙腈 为溶剂, 20.0 ℃ 、250.0 kPa 条件下, 生成 2,6-Bis[3-(4-chlorophenoxy)propyl]pyridine
    参考文献:
    名称:
    Strategies To Reduce hERG K+Channel Blockade. Exploring Heteroaromaticity and Rigidity in Novel Pyridine Analogues of Dofetilide
    摘要:
    Drug-induced blockade of the human ether-a-go-go-related gene K+ channel (hERG) represents one of the major antitarget concerns in pharmaceutical industry. SAR studies of this ion channel have shed light on the structural requirements for hERG interaction but most importantly may reveal drug design principles to reduce hERG affinity. In the present study, a novel library of neutral and positively charged heteroaromatic derivatives of the class III antiarrhythmic agent dofetilide was synthesized and assessed for hERG affinity in radioligand binding and manual patch clamp assays. Structural modifications of the pyridine moiety, side chain, and peripheral aromatic moieties were evaluated, thereby revealing approaches for reducing hERG binding affinity. In particular, we found that the extra rigidity imposed close to the positively charged pyridine moiety can be very efficient in decreasing hERG affinity.
    DOI:
    10.1021/jm301564f
  • 作为产物:
    描述:
    (4-chloro-phenoxy)-acetone semicarbazone 在 selenium(IV) oxide 作用下, 以 溶剂黄146 为溶剂, 反应 5.0h, 生成 1-氯-4-(2-丙炔-1-基氧基)苯
    参考文献:
    名称:
    Shafiee, A.; Toghraie, S.; Aria, F., Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 1305 - 1308
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Cross-Coupling Reactions with 2-Amino-/Acetylamino-Substituted 3-Iodo-1,4-naphthoquinones: Convenient Synthesis of Novel Alkenyl- and Alkynylnaphthoquinones and Derivatives
    作者:Felipe C. Demidoff、Leandro L. de Carvalho、Eduardo José P. Rodrigues Filho、Andréa Luzia F. de Souza、Chaquip D. Netto
    DOI:10.1055/s-0037-1610781
    日期:2021.11
    Functionalized 1,4-naphthoquinones have been employed as versatile synthons in organic synthesis, in addition to presenting a large array of biological activities. Herein, the applications of 2-amino-/ acetylamino-substituted 3-iodo-1,4-naphthoquinones in cross-coupling reactions are described to successfully afford sixteen novel 3-styryl-1,4-naphthoquinones (amino-stilbene-quinone hybrids) and four 3-alkynyl-1
    功能化的 1,4-萘醌除了具有大量的生物活性外,还被用作有机合成中的多功能合成子。在此,描述了 2-氨基-/乙酰氨基取代的 3-碘-1,4-萘醌在交叉偶联反应中的应用,成功提供了 16 种新型 3-苯乙烯基-1,4-萘醌(氨基-二苯乙烯-醌杂化物) ) 和四个 3-炔基-1,4-萘醌,总体收率良好。有趣的是,经过广泛研究以排除 Pd 作为助催化剂后,可以从无配体和无 Pd 的 Cu I介导的交叉偶联反应中获得炔基化衍生物。最后,对脱硅烷的末端炔进行点击化学反应,得到两种新型三唑-1,4-萘醌杂化物。
  • Enantioselective Palladium‐Catalyzed Hydrophosphinylation of Allenes with Phosphine Oxides: Access to Chiral Allylic Phosphine Oxides
    作者:Zhiping Yang、Jun (Joelle) Wang
    DOI:10.1002/anie.202112285
    日期:2021.12.20
    A highly efficient, versatile and atom-economic protocol to chiral allylic phosphine oxides is demonstrated via palladium-catalyzed asymmetric hydrophosphinylation of allenes with phosphine oxides. A family of chiral allylic phosphine oxides with a diverse range of functional groups were obtained in high yield (up to 99 %) and enantioselectivities (up to 99 % ee).
    通过钯催化的丙二烯与氧化膦的不对称氢膦酰化,证明了一种高效、通用和原子经济的手性烯丙基氧化膦方案。以高产率(高达 99%)和对映选择性(高达 99% ee)获得了一系列具有多种官能团的手性烯丙基氧化膦。
  • 1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study
    作者:Mubarak H. Shaikh、Dnyaneshwar D. Subhedar、Laxman Nawale、Dhiman Sarkar、Firoz A. Kalam Khan、Jaiprakash N. Sangshetti、Bapurao B. Shingate
    DOI:10.1039/c5md00057b
    日期:——

    A library of thirty one 1,2,3-triazole derivatives efficiently preparedviaclick chemistry and evaluated for their antitubercular, antioxidant, and cytotoxic activities.

    通过点击化学高效制备了三十一种1,2,3-三唑衍生物库,并评估了它们的抗结核、抗氧化和细胞毒性活性。

  • One-Pot Synthesis of 1,4-Disubstituted 1,2,3-Triazoles from In Situ Generated Azides
    作者:Alina K. Feldman、Benoît Colasson、Valery V. Fokin
    DOI:10.1021/ol048859z
    日期:2004.10.1
    [reaction: see text] 1,4-Disubstituted 1,2,3-triazoles are obtained in excellent yields by a convenient one-pot procedure from a variety of readily available aromatic and aliphatic halides without isolation of potentially unstable organic azide intermediates.
    [反应:见正文]通过便利的一锅法,从各种容易获得的芳族和脂肪族卤化物中,以便利的一锅法获得了1,4-二取代的1,2,3-三唑,而无需分离潜在的不稳定的有机叠氮化物中间体。
  • Design, synthesis and pharmacological analysis of 5-[4′-(substituted-methyl)[1,1′-biphenyl]-2-yl]-1H-tetrazoles
    作者:Atulkumar Kamble、Ravindra Kamble、Suneel Dodamani、Sunil Jalalpure、Vijaykumar Rasal、Mahadev Kumbar、Shrinivas Joshi、Sheshagiri Dixit
    DOI:10.1007/s12272-017-0887-0
    日期:2017.4
    In the present paper 5-[4′-(4-[(4-aryloxy)methyl]-1H-1,2,3-triazol-1-yl}methyl)[1,1′-biphenyl]-2-yl]-1H-tetrazoles (5a–g) and [2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl-substituted-1-carbodithioates (11h–q) have been designed and synthesized. These compounds were subjected to docking (against AT1 receptor protein enzyme in complex with Lisinopril), in vitro angiotensin converting enzyme inhibition
    在本文中 5-[4'-(4-[(4-芳氧基)甲基]-1H-1,2,3-三唑-1-基}甲基)[1,1'-联苯]-2-基]-1H-四唑 (5a-g) 和 [2'-(1H-四唑-5-基)[1,1'-联苯]-4-基]甲基-取代的-1-碳二硫代酸酯 (11h-q)已经设计和合成。这些化合物经过对接(针对与赖诺普利复合的 AT1 受体蛋白酶)、体外血管紧张素转化酶抑制、抗增殖、抗炎筛选(通过卵白蛋白变性抑制和红细胞膜稳定试验),最后抗- 真菌活性分析。一些化合物已显示出显着的药理特性。
查看更多